We are live on
!
Find out more
VI
Vestcor Inc Portfolio holdings
AUM
$3.63B
1-Year Est. Return
21.49%
This Fund
S&P 500
This Quarter
Est. Return
+1.63%
1 Year Est. Return
+21.49%
3 Year Est. Return
+77.59%
5 Year Est. Return
+109.03%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$44.1M
(-1.5%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
16.12%
Holding
1,325
New
120
Increased
512
Reduced
296
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$16M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$11.8M |
| 3 |
Allstate
ALL
|
+$9.58M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.93M |
| 5 |
AT&T
T
|
+$7.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$48.9M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$18.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$10.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$9.55M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$8.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.18% |
| 2 | Consumer Staples | 12.1% |
| 3 | Healthcare | 11.52% |
| 4 | Financials | 11.19% |
| 5 | Consumer Discretionary | 8.35% |
Similar funds
JFG
GCM
ACM
APP
SCM
OCM
WB
SL
Vestcor Inc's Q1 2025 Portfolio in Review
As of Q1 2025, Vestcor Inc held 1,325 positions worth $2.97B, down 1.5% from $3.02B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Vestcor Inc's Q1 2025 filing shows 120 new, 512 increased, 296 reduced and 166 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 128,319 shares worth $16.9M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $48.9M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Staples and Healthcare.
- Vestcor Inc's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 128,319 shares worth $16.9M.
- Vestcor Inc added most to Allstate in Q1 2025, an estimated $9.58M increase.
- Vestcor Inc's biggest Q1 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $10.1M.
- Vestcor Inc fully exited Invesco S&P 500 Equal Weight ETF in Q1 2025, selling an estimated $48.9M.
- Vestcor Inc's ten largest holdings make up 16% of its $2.97B portfolio in Q1 2025.
- Vestcor Inc opened 120 new positions and closed 166 in Q1 2025.
- Vestcor Inc's portfolio value fell 1.5% quarter-over-quarter to $2.97B.
Based on Vestcor Inc's 13F filing for Q1 2025, filed 8 May 2025.